Umbilical cord mesenchymal stem cells (UCMSCs) are highly regenerative, non-invasive, and versatile stem cells derived from umbilical cord tissues such as Wharton's jelly. Their remarkable characteristics make them a promising option for treating various conditions, including tissue damage, autoimmune disorders, and neurological issues.

Key Characteristics and Benefits:

• High Proliferation & Potency: UCMSCs exhibit superior and faster self-renewal and multi-lineage differentiation capabilities compared to bone marrow or adipose-derived stem cells.
• Low Immunogenicity: Their immature nature allows them to lack certain surface markers, enabling their use in allogeneic transplantation without the risk of rejection.
• Immune Regulation & Repair: These stem cells modulate the immune system, reduce inflammation (TNF-α, IL-6), and promote tissue repair in damaged areas.
• Accessible Collection: They can be harvested from umbilical cord tissue, often after C-sections, using non-invasive methods.

Therapeutic Applications:

UCMSCs are being actively researched for a wide range of applications, including:

• Musculoskeletal & Tissue Repair: Effective in treating osteoarthritis, cartilage damage, and bone repair.
• Immune Disorders & Transplantation: Useful in reducing graft-versus-host disease (GvHD), systemic lupus erythematosus, and Crohn's disease.
• Neurological Conditions: Investigated for their potential in treating cerebral palsy, spinal cord injuries, and strokes.
• Liver & Respiratory Diseases: Applied in cases of liver cirrhosis, acute liver failure, and ARDS related to COVID-19.
• Cardiovascular: Relevant in the treatment of acute myocardial infarction and critical limb ischemia.

Please contact bd@cell-bio.life for more details on #MSC collection and processing.

At Cell's Bio we are turning in vitro needs into real life scientific excellence.